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Introduction
Lumbar puncture (LP) and cerebrospinal fluid (CSF) analysis is essential in 
confirming the diagnosis of central nervous system infections and is often helpful 
in assessing of subarachnoid hemorrhage, demyelinating, degenerative diseases and 
intracranial neoplasms (1).
Comfort and immobility of patients are critical to the success of the procedure. If the 
child is not cooperative, procedural sedation should be used to reduce child pain and 
anxiety and to improve kids and their parents’ experience (2, 3). 
Different analgesics and sedative drugs such as topical anesthetic agents (1% 
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Objective 
Reduction of pain of invasive procedures in neonates can prevent pain side 
effects. The purpose of present study was to evaluate the efficacy and safety of 
a single low dose of intravenous fentanyl in reducing of lumbar puncture (LP) 
pain in neonates.
Materials & Methods
In this randomized clinical trial, registered with code number of 
2014022616761N150, admitted neonates to Shahid Sadoughi Hospital, Yazd, 
Iran from August-April 2012 (45 cases) were randomly assigned into two groups 
to receive 2 μg/kg of intravenous fentanyl or 0.2 milliliter of normal saline, two 
min before LP. Primary outcome was success rate in reducing of pain during 
needle insertion to skin (pain score of less than three). Secondary outcomes were 
clinical side effects and serious adverse events.
Results
Forty-five neonates including 23 girls and 22 boys were evaluated. Pain reduction 
was obtained in 39.1% (9 of 23 neonates) of fentanyl group and in 4.5% (one of 
22 neonates) of control group. Means of pulse rate (136.41± 9.16 vs. 148.9± 8.99) 
and pain score during needle insertion (3.41±1.31 vs. 5.8±1.12) were lower in 
fentanyl group. No severe adverse effects were seen in both groups. Side effects 
such as vomiting [9% (N=2) in control and 4.3% (N=1) in fentanyle group] and 
mild transient decrease in oxygen saturation in 8.7% (N=2) of fentanyle group 
were seen. Safety in two groups was not statistically different.
Conclusion
Intravenous fentanyl might be considered as a safe and effective analgesic drug 
in LP in neonates. 
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lidocaine, EMLA cream) (4), propofol and ketamine (5), 
nitrous oxide (6), oral midazolam and oral promethazine 
(7), intravenous fentanyl (8) have been used by 
physicians to reduce pain and stress of LP. However, in 
spite of progress in the efforts done for management and 
reduction of pain in children, they are still not receiving 
satisfactory LP pain control and more improvement can 
still be gained (9).
Newborns experience pain and stress (10) and pain in 
premature neonates can alter hypothalamic–pituitary–
adrenal axis and cortisol secretion regulation. Higher 
neonatal procedural pain exposure in less than 28 wk 
gestational age newborn was related to lower cortisol 
response to stress, besides, high cortisol levels in 
infancy may help to cause greater risks of impaired 
neurodevelopment and less attention (11).
Pain is the most common and severe signs in admitted 
newborns to neonatal intensive care unit (NICU). 
Measurement for reduction, prevention and management 
of pain in neonates during routine care or invasive 
procedures by combination of non-pharmacologic and 
pharmacologic therapies should be provided to reduce 
short-term and long-term side effects of pain (12). 
Opioids such as morphine and fentanyl, which have 
analgesic and sedative effects, a wide therapeutic 
window, and attenuate responses of physiologic stress, 
are the most commonly used drugs for moderate to 
severe pain in neonates (13). 
Fentanyl is a rapid-acting opioid analgesic that in 
comparison to morphine is accompanied by less sedative 
or hypotensive effects, reduced effects on gastrointestinal 
motility or urinary retention (14).   
There are a few randomized clinical trials compared the 
efficacy and safety of fentanyl in placebo in control of 
pain of invasive procedures in neonates. The purpose of 
present research was to evaluate the efficacy and safety 
of bolus dose of intravenous fentanyl in reducing of pain 
of LP in neonates.
Materials & Methods
A parallel single-blinded randomized clinical trial was 
conducted on 45 admitted neonates to NICU of Shahid 
Sadoughi Hospital, Yazd, Iran children who received 
LP to roll up meningitis from August to April 2012. 
The registration number of the research in clinical trial 
website of Iran is 2014022616761N1. 
Informed consent was taken from neonates parents before 
administration of the drugs and the Ethics Committee of 
Shahid Sadoughi University of Medical Sciences, Yazd, 
Iran, approved this clinical trial. 
To determine a 20% difference in efficacy between the 
two groups, with type one error (alpha) of 0.05 and 80% 
power, sample size was estimated as 24 neonates in each 
group.
Eligible participants included NICU admitted neonates 
with gestational age of more than 34 wk, birth weight 
of more than 1800 gr and those who underwent lumbar 
puncture based on clinical judgment of the neonatologist 
of research.
Those with major congenital anomalies, severe hypoxic 
ischemic encephalopathy, neuromuscular disorders, 
hemodynamic or respiratory instability, aged more 
than two months, decrease in the level of consciousness 
(Glasgow Coma Scale less than 10), used sedative or 
analgesic drugs 12 h before LP or whose parents refused 
to consent, and were excluded. Simple randomization of 
the study was computer generated by random numbers 
and allocation ratio was 1:1 for the three groups. 
The nurse of research, not involved in the trial, did the 
randomisation and blinding. Data gatherers, outcome 
assessors and data analysts were all allocation blinded.
A trained NICU nurse was in charge of allocating 
each neonate in the randomized treatment group, and 
she guaranteed that the two preparations would not 
differentiate. The drugs were delivered by a nurse and 
primary and secondary outcomes were assessed by the 
pediatric resident of research who had no information of 
the sedation regimens group assignment. 
Fifty consecutive neonates who had inclusion criteria 
of research were randomly assigned to two groups to 
receive 2 μg/kg of intravenous (IV) fentanyl (ampoule of 
0.5 mg in 10 milliliter of Caspian Tamin pharmaceutical 
Co, Iran) diluted to 0.2 ml of normal saline (Group I) or 
0.2 ml of normal saline (Samen pharmaceutical Co, Iran) 
as placebo (Group II).
In both groups, the drugs were given intravenously two 
min before undergoing of LP and LP was performed 
with a trained and experienced pediatric resident, a 
similar needle size and in seated position.
Pulse rate, respiratory rate, blood pressure, and saturation 
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of oxygen (SaO2) were measured two min before drugs 
administration and when the needle was inserted and 
then pulse oximetry continued and oxygen saturation 
continuation were measured every two min during the 
first 10 min after LP by the pediatric resident of research.
Obtaining pain score of three based on Neonatal Infant 
Pain Scale or NIPS (15) during needle insertion to skin 
was considered as sufficient analgesia.
Primary outcome was success rate in reducing of pain 
when the needle was inserted to skin for LP (pain score 
of less than three). Secondary outcomes were clinical 
adverse events and severe side effects.
Apnea and assisted ventilation respiratory depression, 
cyanosis and SaO2 of less than 70%, significant and 
persistent hypotension (systolic arterial pressure of less 
than 70 mmHg or 30% or greater decrease in before 
sedative drug taking mean arterial blood pressure for 
more than 60 sec), bradycardia (pulse rate less than 60 
in min), arrhythmia, seizure and chest wall rigidity, were 
considered as severe adverse events.
The data were analyzed using SPSS 17 statistical 
software (Chicago, IL, USA). Recorded data were 
assessed for normal distribution using the Kolmogorov-
Smirnov test and Chi-square test was used for data 
analysis of qualitative variables and mean values were 
compared using independent t-test. P values of less than 
0.05 were taken as significant different. 
Results
In group 1, two neonates with severe hypoxic ischemic 
encephalopathy and in group 2, one neonate with 
neuromuscular disorders and two neonates whom 
received phenobarbital, were excluded and finally 45 
neonates including 23 girls (51%) and 22 boys (49%) 
were evaluated (Figure 1).
By Kolmogorov-Smirnov test, the data had normal 
distribution.
Table1 shows comparison of demographic characteristics, 
rout of delivery and pulse rate and oxygen saturation 
before drug administration in neonates of the two groups 
which indicated that sex distribution, rout of delivery, 
mean of age, mean of weight, mean of gestational age, 
mean of pulse rate and oxygen saturation before drug 
administration were not statistically significant different 
in two groups. 
Table 2 compares mean of pulse rate during needle 
insertion and mean of oxygen saturation during, two, 
four, six, and eight min after drug administration in the 
neonates of two groups, which shows that neonates in 
IV fentanyl group had lower pulse rate and pain score 
during needle insertion. Saturation of oxygen drug 
administration of two, four, six, eight and ten min after 
drug administration were not statistically significant 
different in both groups. 
Pain reduction or achieving the pain score of less than three 
was obtained in nine neonates (39.1%) in intravenous 
fentanyl (95% confidence interval: 19.16% to 59.04%) 
and in one neonate (4.5%) in control (95% confidence 
interval: 4.16% to 13.16%) groups, respectively. 
Statistical analysis showed that intravenous fentanyl was 
an effective drug in reduction of lumbar puncture pain in 
neonates (P= 0.001).  No life-threatening or serious side 
effect was seen in both groups. 
Clinical adverse effects such as vomiting [9% (N=2) in 
control group and 4.3% (N=1) in intravenous fentanyle 
group] and mild transient decrease in oxygen saturation 
(SaO2 =85%) immediately corrected by oxygen 
therapy in 8.7% (N=2) of fentanyle group were seen. 
No statistically significant differences were seen from 
viewpoint of safety between the two groups.
Discussion
Prevention and control of pain in neonates that 
includes routine assessments of pain, decreasing the 
number of painful procedures, use of pharmacologic 
and nonpharmacologic techniques in routine minor 
procedures, treatment of surgery, invasive procedures, 
pain, avoidance of chronic pain and stress during 
neonatal intensive care, has short-term and long-term 
benefits (12).
Insufficient relief of children’s procedural pain and 
distress affects the experience of them as well as their 
parents and has adverse impacts on procedural success 
as well (16).
LP is one of the most frequent painful diagnostic 
procedures historically been done without local 
anesthesia, specifically in neonates (9). In Italy, only 
in 58% of NICU admitted neonates analgesia was used 
before LP (17). However, use of sedation drugs before 
LP can reduce incidence of traumatic LP (18).
IV Fentanyl in LP
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Intravenous fentanyl can be used in neonates 
that provides rapid analgesic effect with the least 
hemodynamic effects. In some studies, fentanyl has been 
used for achieving analgesia prior to tracheal intubation 
in preterm and term newborns and in ventilated preterm 
neonates. (13, 19, 20)
Today, nitrous oxide is used for induction of sedation 
and analgesia in minor pediatric procedures such as 
LP and laceration repair. However, the drug might be 
associated with clinical seizure activity (21).
Our results showed that single dose of 2 μg/kg of 
intravenous fentanyl can be effective in reducing of pain 
of LP in term NICU admitted neonates.
Combination of fentanyl and propofol (22) in addition to 
fentanyl and midazolam (23) for invasive procedures in 
children with acute leukemia (22, 23) or lymphoma (22) 
reduced child movement.
In Italy, administration of 1-2 μg/kg of fentanyl in 
premature neonates before heel lancing provided a more 
analgesic effects and reduction in the pain score than 
facilitated tucking (24).
In the present study, administration of intravenous in 
fentanyl attenuated more heart rate increased than in 
control group. In another Iranian study, IV fentanyl 
attenuated more heart rate increased than sufentanil, 
alfentanil or remifentanil and hemodynamic stability 
was better kept with fentanyl (25).
In the present study, a single low dose of IV fentanyl 
in ≥ 34 wk gestational age neonates was safe and life 
threatening and severe adverse events were not seen in 
any neonates. Combination of low dose of IV fentanyl 
and midazolam was effective and safe in reduction of 
LP pain in 2-7 yr old children (26). However, chest wall 
rigidity is one of serious side effects of fentanyl and other 
synthetic opioids, especially, if the drug is administered 
with rapid and high doses and in neonates and infants 
(27). 
In conclusion, a single low dose of 2 μg/kg of intravenous 
fentanyl two min before Lp of near term neonates is safe 
and effective in reduction of this procedural pain. Results 
of this research can be viewed as being promising and 
future clinical trials with larger sample size study should 
be performed for definite proof of fentanyl.
IV Fentanyl in LP
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Fig1. CONSORT 2010 Flow Diagram
Table 1. Comparison of Demographic Characteristics, Rout of Delivery and Pulse Rate and Oxygen Saturation before 
Drug Administration in Neonates of the Two Groups
Data Normal saline Intravenous fentanyl P. value
Sex
Female (%) 11(50) 12 (47)
0.6
Male (%) 11 (50) 11 (53)
Rout of delivery
Vaginal (%) 10 (45.5) 11 (47)
0.9
Cesarean section (%) 12 (54.5) 12 (53)
Age  in days (yr) (mean ±SD) 28.61 ± 11.32 29.14± 10.64 0.8
Weight in grams (mean ±SD) 3312.7 ± 892.1 3360.8 ± 934.3 0.8
Gestational age in weeks (mean ±SD) 37.6 ± 0.6 37. 4± 0.8 0.3
Pulse rate before drug administration (mean ±SD) 137.1 ± 9.83 134.81 ± 9.31 0.4
Oxygen saturation before drug administration (mean ±SD) 96.31 ± 2.11 95.87 ± 2.65 0.7
IV Fentanyl in LP
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Table 2. Comparison of Mean of Pulse Rate During Needle Insertion and Mean of Oxygen Saturation During, 2, 4, 6 








Pulse rate during needle insertion 148.9 ± 8.99 136.41 ± 9.16 0.001
Oxygen saturation during drug administration 96.11 ± 2.23 96.21 ±1.81 0.8
Oxygen saturation two minutes after drug administration 95.82 ± 2.25 94.51± 2.87 0.9
Oxygen saturation four minutes after drug administration 94.86 ± 2.51 94.52 ± 3.34 0.7
Oxygen saturation six minutes after drug administration 96.11 ± 2.31 95.18 ± 2.84 0.9
Oxygen saturation eight minutes after drug administration 95.76 ± 2.36 96.31 ± 2.55 0.7
Oxygen saturation ten minutes after drug administration 96.31 ± 2.46 96.25 ± 2.78 0.9
Pain score during needle insertion 5.8 ± 1.12 3.41± 1.31 0.001
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